GNTI-122

· GentiBio, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for GNTI-122, covering 2026-04-13 to 2026-04-13. Get the full timeline:

Most recent: Clinical Trial Update: A Study of GNTI-122 in Adults Recently Diagnosed With T1D [Phase 1]